2026-10-14T08:16:25Z https://api.figshare.com/v2/oai

oai:figshare.com:article/33809363 2026-09-15T17:23:10Z category_7 category_14 category_21 category_46 category_734 category_106 category_128 category_132 category_134 portal_5 item_type_3 month_year_09_2026

<p>De-identified individual-level clinical dataset underlying the main findings of this study.</p> Makoto Yamaguchi (588823) Hirokazu Sugiyama (5130476) Hiroshi Kinashi (7047896) Keisuke Kamiya (9339137) Genri Tagami (20600334) Masayoshi Toda (24947738) Takayuki Katsuno (588826) Takahiro Imaizumi (3138777) Shogo Banno (7047899) Yasuhiko Ito (588831) Takuji Ishimoto (119954) Medicine Molecular Biology Biotechnology Immunology Biological Sciences not elsewhere classified Science Policy Hematology Infectious Diseases Virology directed glucocorticoid tapering 73 &# 8211 3 &# 8211 21 &# 8211 33 months ), initial treatment strategy xlink "> relapse relapse treatment strategy relapse treatment intensification 5 months ). second relapse occurred patients achieved remission managed without mmf based maintenance according whereas three patients added group experienced iqr ], 0 treatment allocation second relapse remission induction categorized according based maintenance 4 months 28 months three patients 8 ). added group first relapse mycophenolate mofetil independent effect evidence regarding evaluated descriptively concomitant therapies clinical problem associated vasculitis 76 years <p>De-identified individual-level clinical dataset underlying the main findings of this study.</p> 2026-09-15T17:23:05Z Dataset Dataset 10.1371/journal.pone.0357836.s003 https://figshare.com/articles/dataset/_p_De-identified_individual-level_clinical_dataset_underlying_the_main_findings_of_this_study_p_/33809363 CC BY 4.0